Letters: Developmental Toxicity Risk Assessment: What's Really Important?

Daston GP , Rogers JM , Versteeg DJ , Sabourin TD , Baines D , Marsh SS (1991) Interspecies comparisons of A/D ratios are not constant across species. Fund Appl Toxicol 17:696–722.

Gaylor DW . (1992) Incidence of developmental defects at the no observed adverse effect level (NOAEL). Reg Toxicol Pharmacol 15:151–60.

Hoar RM . (1995) Developmental toxicity: exptrapolation across species. J Am Coll Toxicol 14:11–20.

Johnson EM . (1987) A tier system for developmental toxicity evaluations based on considerations of exposure and effect relationships. Teratology 35:405–27.

Johnson EM , Newman LM , Gabel BEG , Boerner TE , Dansky LA . (1988) An analysis of the Hydra assay's applicability and reliability as a developmental toxicity prescreen. J Am Coll Toxicol 7:111–26.

Rogers JM . (1987) Comparison of maternal and fetal toxic dose responses in mammals. Teratogen Carcinogen Mutagen 7:297–306.

Schardein JL . (1987) Approaches to defining the relationship of maternal and developmental toxicity. Teratogen Carcinogen Mutagen 7:255–71.

Setzer RW , Rogers JM . (1991) Assessing developmental hazard: the reliability of the A/D ratio. Teratology 44:653–65.